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Abstract
Metastatic	pulmonary	calsification	(MPC)	is	a	metabolic	lung	disease	characterized	by	the	deposition	of	calcium	in	pulmonary	
parenchyma.	It	may	occur	due	to	many	bening	or	malign	pathologies.	Especially	it	is	most	commonly	seen	in	patients	with	end	
stage	chronic	renal	failure	received	renal	replacement	treatment.	The	case	we	report	here	involved	a	history	of	renal	transplan-
tation	about	22	months	ago.	His	thorax	computed	tomography	had	demonstrated	bilateral	disseminated	infiltrations	with	gro-
und-glass	densities	predominantly	in	the	upper	lobes	and	it	was	seen	partially	preserved	subpleural	areas	and	basal	zones.	The	
histopathological	results	in	transbronchial	lung	biopsy	indicated	metastatic	pulmonary	calsification.	We	wanted	to	discuss	patient	
with	the	accompaniment	of	literature. 
Key words: diffuse	pulmonary	 infiltration,	 immunosuppressed	patient,	 renal	 transplantation,	chronic	 renal	 failure,	metastatic	
pulmonary	calsification
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Introduction
Metastatic pulmonary calsification (MPC) 
is a metabolic lung disease characterized by the 
deposition of calcium in pulmonary parenchyma. 
It may develop with many diseases causing hyper-
calcemia. The causes related to benign conditions 
include chronic renal failure, primary or seconda-
ry hyperparathyroidism, excessive exogenous ad-
ministration of calcium and vitamin D, sarcoido-
sis, milk-alkali syndrome, osteoporosis and Paget’s 
diseases. And the etiologies of malignant nature 
are multiple myeloma, parathyroid carcinoma, 
leukemia, lymphoma, breast carcinoma, synovial 
carcinoma, choriocarcinoma, malignant melano-
ma, hypopharyngeal squamous carcinoma. MPC 
is defined as the deposition of calcium in normal 
lung tissue without tissue damage and due to chro-
nically elevated calcium-phosphorus products. 
On the contrary, in dystrophic calcification serum 
calcium levels are normal. Calcium phosphate 
crystals come into existence on necrotic or infla-
med cells. Uncommonly, MPC is seen in patients 
with normal renal functions, normal calcium and 
phosphate levels and without underlying lung 
disease [1–10]. Chest radiographs of MPC reveal 
multiple diffuse calcified nodulesand confluent 
or patchy airspace opacities simulating diffuse in-
terstitial process, pulmonary edema, pneumonia, 
alveolar hemorrhage, hypersensitivity pneumoni-
tis, vasculitis, sarcoidosis, chronic eosinophilic 
pneumonia, occupational lung disease and pul-
monary alveolar microlithiasis [11, 12].
Case report
A 43-year-old male patient was referred to 
emergency department with complaints of dysp-
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Figure 1.	Initial	chest	radiograph Figure 2.	Initial	thorax	computed	tomography
Figure 3.	Calsifications	are	seen	on	skin	and	muscle	structure	out	of	bronchial	mucosa
nea and fever. His symptoms had persisted for 
two months and he observed a progression of 
dyspnea especially the previous week. There was 
a history of renal transplantation due to chronic 
renal failure about 22 months ago. His mainte-
nance of immunosuppressive therapy consisted 
of prednisolone, tacrolimus and mycophenolate 
mofetil. There were no characteristics in his fa-
mily history. The physical examination revealed 
bilateral decreased breathing sounds. Oxygen sa-
turation was 98% in room air and his temperature 
was 36.7°C. Laboratory tests showed hemoglobin 
11 g/dL, platelet 135 109/L, CRP 4.18 mg/dL, cre-
atinine 1.34 mg/dL, albumin 3.3 g/dL, alkalane 
phosphatase (ALP) 32 U/L, serum sodium level 
124 mmol/L, serum potassium level 4.29 mmol/L, 
serum calcium level 8 mmol/L, serum phosphate 
level 2.8 mmol/L. Chest X-ray disclosed bilateral 
nonhomogeneous densities, predominantly in the 
upper and mid zones (Fig. 1). Thorax computed 
tomography demonstrated diffuse bilateral gro-
und-glass opacities, predominantly in the upper 
lobes, while subpleural and basal areas were se-
mi-conserved. Also, on mediastinal sections, cal-
sifications are seen on skin and muscle structure 
out of bronchial mucosa (Figs 2, 3). The patient 
was hospitalized with a pre-diagnosis of pneumo-
nia, tuberculosis, drug-induced pneumonitis, 
noninfectious complications of renal transplan-
tation. According to the subject’s medical history 
and bilateral diffuse involvement on radiological 
imagings, viral infections, especially pneumocy-
stis jiroveci, citomegalovirus (CMV), gram-nega-
tive bacterial infections, staphylococcus aureus 
infection, tuberculosis were initially considered. 
Piperacillin/tazobactam, linezolid, trimethoprim 
sulfamethoxazole therapy was introduced even 
though clinically no pneumocystis jiroveci was 
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considered but could not be ruled out radiolo-
gically with normal oxygen saturation patient. 
Blood, sputum and urine cultures were taken. 
Respiratory tract panel (microarray), blood IgM 
of CMV, EBV, HSV and PCR for BK virus (BKV) 
were studied. On the second day of the hospita-
lization bronchoscopy, bronchoalveolar lavage 
(BAL) and transbronchial lung biopsy were 
performed. There was no growth in cultures of 
the patient who was receiving antibiotherapy for 
fourteen days. Rhinovirus growth in respiratory 
tract panel (microarray), Herpes simplex virus 
(HSV), Epstein-Barr virus (EBV), CMV, BKV PCR 
were detected negative. With the negative results 
of bronchoalveolar lavage culture, following a 
transbronchial lung biopsy, pulmonary metastatic 
calcification was finally diagnosed in the patient. 
The reported case reminds of the possibility of 
metastatic pulmonary calsification in differan-
tial diagnosis of noninfectious causes of diffuse 
pulmonary infiltrations in patients with chronic 
renal failure and renal transplantation.
Discussion 
Metastatic calsification means deposition 
of calcium in normal tissue. The lung is the one 
of the main area of metastatic calsification [1]. 
Metastatic calcification of pulmonary parenchy-
ma correlate with chronically elevated calcium-
phosphorus products as chronic renal failure, 
primary hyperparathyroidism, hypervitaminosis 
D, milk-alkali syndrome, multiple myeloma [2]. 
Calcium salts accumulate predominantly in the 
alveolar epithelial basement membranes, and to 
a lesser extent, the bronchial walls, pulmonary 
arteries and vascular structures [3]. Calcium accu-
mulation occurs denser in alkaline environments. 
Metastatic pulmonary calsification usually occurs 
in the upper zones of the lung due to a more alka-
line environment in the upper zones than basal 
areas [2]. The degree of respiratory distress is 
often uncorrelated with the degree of calsification 
in radiological findings. Patients with extensive 
parenchymal calcification may be asymptoma-
tic, whereas those with subtle calcification or 
normal chest radiographs may have severe re-
spiratory compromise [4]. Metastatic pulmonary 
calsification is a well established complication 
of end- stage renal failure and its treatment [5]. 
This interstitial process is characterized by the 
deposition of calcium salts, predominantly in 
the alveolar epithelial basement membranes. 
MPC is seen at autopsy in 60–75% of patients 
with renal failure. It is often asymptomatic but 
can potentially progress to respiratory failure [11]. 
Our patient with renal failure and renal 
transplantation had no severe symptoms limiting 
his daily activity even though bilateral diffuse 
lesions were seen in his lung radiogram. Stan-
dard chest radiographs have poor sensitivity 
for the identification of metastatic pulmonary 
calsification in the parenchyma. Metastatic pul-
monary calcifications have been described as 
airspace opacities simulating pulmonary edema 
or pneumonia on chest radiographs. Metastatic 
pulmonary calcifications can also appear as an 
interstitial pattern or diffuse calcific nodules 
on chest X-ray [2, 6]. High-resolution computed 
tomography (HRCT) has high sensitivity for the 
detection and characterization of parenchymal 
calcification. HRCT shows frequently three ra-
diological patterns for malignant pulmonary 
calsification. These are bilateral calcific nodular 
lesions predominantly in the upper lobes, patchy 
areas of groundglass opacity or consolidation, 
and finally, a parenchymal consolidation with 
a predominantly lobar distribution. The diffe-
rential diagnosis of MPC include pulmonary 
edema, pneumonia, atypical infections, recurrent 
alveolar hemorrhage, hypersensitivity pneumoni-
tis, vasculitis, sarcoidosis, chronic eosinophilic 
pneumonia, pulmonary metastasis (osteogenic 
sarcoma,  chondrosarcoma, thyroid malignan-
cies), miliary tuberculosis. histoplasmosis, fungal 
infections, varicella pneumonia, occupational 
lung disease (silicosis, coal workers’ pneumoco-
niosis, siderosis, stannosis, and baritosis), chro-
nic hemorrhagic conditions, rheumatic mitral 
stenosis, and pulmonary alveolar microlithiasis 
[11–13]. As these patients are highly immuno-
suppressed, infection should always be excluded. 
In our case, HRCT revealed diffuse ground-glass 
opacities. Blood, sputum and urine cultures, 
respiratory tract panel (microarray), blood IgM 
of CMV, EBV, HSV and PCR for BK virus were 
evaluated to investigate infectious agents due to 
immunodeficiency in the patient. Also, broncho-
alveolar lavage cultures were negative. Following 
a bronchoscopic parenchymal biopsy, pulmonary 
metastatic calcification was finally diagnosed in 
the man. 
Dual-energy digital chest radiography has 
been reported to be more sensitive and accurate 
than standard chest radiography for the detection 
of MPC. However, this technique is not widely 
used, most likely due to the availability and 
advantages of  computed tomography  (CT) for 
the assessment of patients suspected of other 
respiratory problems  [12]. In our case, dual-e-
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nergy digital chest radiography was not used, we 
had observed calcifications on skin and muscle 
structure computed tomography [11].
Nuclear medicine studies are used for early 
detection of metastatic pulmonary calcification. 
Technetium-99m bone scanning is one of the 
sensitive techniques to detect pulmonary calci-
fication. In addition, this technique with SPECT 
(single-photon emission computed tomography) 
may allow detection and localization of the lesion 
[4]. In our patient, bone scintigraphy or SPECT 
were not performed. 
The findings of pulmonary function tests are 
usually normal in patients with MPC [9]. Alveolar 
septa are diffusely involved in MPC, diffusing 
capacity is decreased. Restrictive and diffusion 
defects may appear, even when chest radiography 
appears normal. Vital capacity has been inversely 
correlated with severity of calcification [10].
Although the optimal treatment of meta-
static pulmonary calcification is not known, 
attempts to normalize calcium and phosphate 
biochemistry have been the mainstays of the 
therapy [14]. An increase in the dialysis dose 
is indicated for patients with end-stage renal 
disease [15]. There is no certain data about the 
course of MPC after renal transplantation. Some 
studies have shown regression of the lesions, 
whereas others have revealed progression after 
transplant [16]. In conclusion, MPC is frequently 
associated with end-stage renal failure and is 
rarely diagnosed because of being asymptoma-
tic. It may progress to irreversible lung injury 
and respiratory failure. MPC should be kept in 
mind when unexplained radiographic changes 
or pulmonary symptoms develop in dialysis 
patients. HRCT or Tc99m-MDP bone scanning 
can be helpful for diagnosis and may obviate 
the need for open lung biopsy. 
Noninfectious causes and metastatic pulmo-
nary calcifications in the differential diagnosis of 
diffuse pulmonary infiltrates were discussed with 
the accompaniment of the literature.
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